Download
HTML Embed
HTML EMBED
Click to Copy
Marketplace Morning Report

A year-and-a-half late and $1 million short

Aug 23, 2019

Latest Episodes

Download
HTML Embed
HTML EMBED
Click to Copy
Marketplace Morning Report
Download
HTML Embed
HTML EMBED
Click to Copy
Download
HTML Embed
HTML EMBED
Click to Copy
Download
HTML Embed
HTML EMBED
Click to Copy
This Is Uncomfortable
Download
HTML Embed
HTML EMBED
Click to Copy
Marketplace Morning Report
Download
HTML Embed
HTML EMBED
Click to Copy
Marketplace Morning Report
Download
HTML Embed
HTML EMBED
Click to Copy
Marketplace Morning Report
Download
HTML Embed
HTML EMBED
Click to Copy
Download
HTML Embed
HTML EMBED
Click to Copy
Download
HTML Embed
HTML EMBED
Click to Copy
Marketplace Morning Report

A last-minute ruling means TV ads won't list drug prices as planned

by Daniel Merino Jul 9, 2019
Some experts doubt that the rule would have been capable of lowering drug prices.
George Frey/Getty Images

New gene therapy drug expected to hit market with head-spinning price tag

by Kimberly Adams May 22, 2019
Industry analysts expect the price for the single-treatment therapy to be anywhere from $1.5 million to $5 million.
Swiss pharmaceutical giant Novartis' Basel headquarters.
SEBASTIEN BOZON/AFP/Getty Images

Would requiring prices in pharmaceutical ads make drugs cheaper?

by Andy Uhler Apr 9, 2019
The idea is that transparency would lead to more competition and lower costs. One drug company is already on board.
Philippe Huguen/AFP/Getty Images

Walgreens has a tough quarter

by Jack Stewart Apr 2, 2019
Pharmacy chain Walgreens reported a 3.8 percent drop in sales for the quarter. The company cited a weak cough, cold and flu season — and declining profits from generic and branded prescription drugs. Click the audio player above to hear…
People walk by a Walgreens store in San Francisco. The pharmacy industry thinks bigger is better to find cost savings.
Justin Sullivan/Getty Images

FDA approves new Johnson & Johnson drug for depression

by Renata Sago Mar 6, 2019
The Food and Drug Administration has approved the first new kind of drug to treat depression since Prozac hit the scene in the late 1980s. Spravato is a nasal spray from Johnson & Johnson that’s a close cousin of ketamine, an…
Janssen Pharmaceutica

Kickbacks or a helpful service? Here's why pharma is under fire

by Mitchell Hartman Sep 21, 2018
Drug companies can get creative with doctor incentives, and that can be problematic.
A pharmacy technician counts out a prescription of antibiotic pills.
Joe Raedle/Getty Images

House passes measure giving terminally ill patients more access to experimental drugs

by Amy Scott May 23, 2018
More patients who are terminally ill will potentially have access to experimental drugs under a measure passed by the House last night. President Donald Trump is expected to sign the so-called “right-to-try” bill. Forty states have already passed similar legislation.…

Invest in Marketplace today

Ask not what Marketplace can do for you, but what you can do for Marketplace.

Those coupons people use for expensive meds are starting to count for less

by Dan Gorenstein Mar 19, 2018
Insurers are pushing back on manufacture coupons for expensive drugs in the hopes that it will pressure drug companies to lower prices.
A pharmacy manager assists a shopper in the pharmacy area of a Walmart store in Mount Prospect, Illinois.
Tim Boyle/Getty Images

Beautycounter CEO wants more regulation for safer products

by Kai Ryssdal, Bridget Bodnar, and Paulina Velasco Mar 1, 2018
"I set out to get safer products into the hands of everyone," Gregg Renfrew says.
“You may buy something that says all natural or botanical or pure, but it may be none of the above, and so consumers are misled by companies today,” says Beautycounter CEO Gregg Renfrew.
CHARLY TRIBALLEAU/AFP/Getty Images
The Uncertain Hour

How one sentence helped set off the opioid crisis

by Caitlin Esch Dec 13, 2017
Recently unsealed documents shed light on how the maker of OxyContin seems to have relied more on focus groups than on scientific studies to create an aggressive and misleading marketing campaign that helped fuel the national opioid epidemic.
A candlelight vigil recognizing the nation's opioid addiction crisis in Washington, D.C.
Alex Wong/Getty Images